Lv11
70 积分 2024-05-10 加入
The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics
7天前
已完结
Low positivity rate of fibroblast growth factor receptor 2b is associated with heterogeneous expression in gastric cancer
9天前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Inflammasome components as new therapeutic targets in inflammatory disease
3个月前
已完结
[Updates in the 5(th) edition of WHO classification of tumours of the breast]
3个月前
已完结
美国临床肿瘤学会／美国病理医师学院乳腺癌雌、孕激素受体免疫组织化学检测指南简介
3个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
4个月前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
5个月前
已完结
皖公网安备34019202002308
